Michael P. Dube

Insider Reports History

Location
Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael P. Dube:

Company Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. VP, Chief Accounting Officer Common Stock 69,527 $868,392 $12.49 01 Mar 2026 Direct

Insider Reports Filed by Michael P. Dube

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTLA Intellia Therapeutics, Inc. 01 Mar 2026 1 $0 4 VP, Chief Accounting Officer 03 Mar 2026, 16:15
NTLA Intellia Therapeutics, Inc. 05 Jan 2026 1 -$27,529 4 VP, Chief Accounting Officer 07 Jan 2026, 16:01
NTLA Intellia Therapeutics, Inc. 01 Oct 2025 1 -$32,518 4 VP, Chief Accounting Officer 03 Oct 2025, 17:13
NTLA Intellia Therapeutics, Inc. 02 Jul 2025 1 -$24,905 4 VP, Chief Accounting Officer 03 Jul 2025, 16:07
NTLA Intellia Therapeutics, Inc. 01 Mar 2025 1 $0 4 VP, Chief Accounting Officer 04 Mar 2025, 16:28
NTLA Intellia Therapeutics, Inc. 03 Jan 2025 1 -$16,711 4 VP, Chief Accounting Officer 07 Jan 2025, 17:23
NTLA Intellia Therapeutics, Inc. 02 Oct 2024 1 -$38,248 4 VP, Chief Accounting Officer 04 Oct 2024, 17:29
NTLA Intellia Therapeutics, Inc. 01 Jul 2024 1 $0 4 VP, PAO and Interim PFO 03 Jul 2024, 13:15
NTLA Intellia Therapeutics, Inc. 10 Apr 2024 0 $0 3 Principal Accounting Officer 22 Apr 2024, 16:10